Kurtzke multiple sclerosis rating scale

Known as: EDSS, Expanded Disability Status Scale, Kurtzke Expanded Disability Status Scale 
A system for quantifying disability in multiple sclerosis (MS). Based on a standard neurological examination, the Expanded Disability Status Scale… (More)
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2013
Highly Cited
2013
BACKGROUND The Patient Determined Disease Steps (PDDS) is a promising patient-reported outcome (PRO) of disability in multiple… (More)
  • table 2
  • table 1
  • figure 1
  • table 3
  • table 4
Is this relevant?
Highly Cited
2008
Highly Cited
2008
Clinically isolated syndromes (CIS), such as optic neuritis, brainstem or spinal cord syndromes are frequently the first clinical… (More)
  • table 1
  • table 2
  • table 3
  • figure 1
  • table 4
Is this relevant?
Highly Cited
2005
Highly Cited
2005
BACKGROUND There is no consensus method for determining progression of disability in patients with multiple sclerosis (MS) when… (More)
Is this relevant?
Highly Cited
2003
Highly Cited
2003
OBJECTIVE To determine the percentage of patients with residual deficits following multiple sclerosis (MS) exacerbations and the… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Highly Cited
2000
Highly Cited
2000
When developing his disability scales for multiple sclerosis, Kurtzke demonstrated perception and insight. However, 45 years… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?
Highly Cited
1999
Highly Cited
1999
The primary clinical outcome measure for evaluating multiple sclerosis in clinical trials has been Kurtzke's expanded disability… (More)
  • table 1
  • table 2
  • table 3
  • figure 1
  • figure 2
Is this relevant?
Review
1999
Review
1999
Clinical outcome assessment in Multiple Sclerosis (MS) is challenging due to the diversity and fluctuating nature of MS symptoms… (More)
Is this relevant?
Highly Cited
1999
Highly Cited
1999
OullII;l y Many clinical rating scales have been proposed to assess the impact of multiple sclerosis on patients, but only few… (More)
Is this relevant?
Highly Cited
1995
Highly Cited
1995
We studied copolymer 1 (Copaxone) in a multicenter (11-university) phase III trial of patients with relapsing-remitting multiple… (More)
Is this relevant?
Highly Cited
1983
Highly Cited
1983
One method of evaluating the degree of neurologic impairment in MS has been the combination of grades (0 = normal to 5 or 6… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • table 6
Is this relevant?